P3S (p.Pro3Ser) variant of AGT (Angiotensinogen)
P3S (p.Pro3Ser) in AGT (Angiotensinogen) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.38 / 1. The record also includes population frequency data and structural context.
P3S (p.Pro3Ser) variant details
- p.Pro3Ser
- rs1319418379
- NCI-TCGA Cosmic COSV6418
- TOPMed rs1319418379
- gnomAD rs1319418379
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.384
- AlphaMissense 0.08
- MetaLR 0.38
- MetaSVM -0.61
- PolyPhen-2 0.03
- SIFT 0.02
- MutPred 0.59
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available